Chemical Name: 2-((8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetaldehyde compound with (8S,9R,10S,11S,13S,14S,16R,17S)-17-(2,2-dihydroxyacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one (1:1)
Smiles: C[C@@]12[C@@H](C(C=O)=O)[C@H](C)C[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3(F)[C@@H](O)C2)=O.C[C@@]56[C@@H](C(C(O)O)=O)[C@H](C)C[C@@]5([H])[C@]7([H])CCC8=CC(C=C[C@]8(C)[C@@]7(F)[C@@H](O)C6)=O
Inchi: InChI=1S/C22H31FO4/c1-12-8-16-15-5-4-13-9-14(25)6-7-21(13,3)22(15,23)18(27)10-20(16,2)19(12)17(26)11-24/h9,12,15-16,18-19,24,27H,4-8,10-11H2,1-3H3/t12-,15+,16+,18+,19-,20+,21+,22+/m1/s1
Identification, characterization of degradation component in desoximetasone pharmaceutical dosage forms and its quantification in the presence of process related impurities
P. Srinivasu, K. Sudhakarbabu, and J. Sreeramulu.
Journal of Liquid Chromatography & Related Technologies, 35:1114–1129, 2012.
Development and Validation of RP-HPLC Method for Desoximetasone in Bulk and Cream Formulation
Ashish Gorle, Jayashri Mahajan, Prathamesh Bhave.
Journal of Drug Delivery & Therapeutics. 2019; 9(3):154-159.